Biotech by today's price change
How far the share price has moved since the previous close.
Repligen leads the 24 biotech ranked by today's price change, at +5.60%, ahead of ImmunityBio (+5.59%) and Scholar Rock Holding (+4.48%). Figures as of 18 Nov 2026, 16:31 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 24
- First
- Repligen+5.60%
- Median
- -0.16%
- Combined market value
- PLN 3.39T
- Countries
- 5
Market values as of .
All countries▾
All sectors▾
Biotech▾
| # | Company | Today ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | RepligenRGEN · Health Care | +5.60% | PLN 44.1B | PLN 689.61 | 5.60% up | 5% up | ||
| 2 | ImmunityBioIBRX · Health Care | +5.59% | PLN 28.3B | PLN 26.61 | 5.59% up | 193% up | ||
| 3 | Scholar Rock HoldingSRRK · Health Care | +4.48% | PLN 23.1B | PLN 189.65 | 4.48% up | 14% up | ||
| 4 | CRISPR TherapeuticsCRSP · Health Care | +4.16% | PLN 16.3B | PLN 168.39 | 4.16% up | 21% down | ||
| 5 | Krystal BiotechKRYS · Health Care | +3.86% | PLN 37B | PLN 1,248.44 | 3.86% up | 46% up | ||
| 6 | Twist BioscienceTWST · Health Care | +3.35% | PLN 31.8B | PLN 466.06 | 3.35% up | 340% up | ||
| 7 | CG OncologyCGON · Health Care | +1.25% | PLN 28.7B | PLN 321.83 | 1.25% up | 85% up | ||
| 8 | Halozyme TherapeuticsHALO · Health Care | +1.18% | PLN 44.6B | PLN 390.99 | 1.18% up | 37% up | ||
| 9 | ImmunovantIMVT · Health Care | +1.08% | PLN 28B | PLN 135.17 | 1.08% up | 43% up | ||
| 10 | ExelixisEXEL · Health Care | +0.96% | PLN 67.9B | PLN 278.47 | 0.96% up | 63% up | ||
| 11 | Bio-TechneTECH · Health Care | +0.14% | PLN 46B | PLN 292.84 | 0.14% up | 26% up | ||
| 12 | Kodiak SciencesKOD · Health Care | +0.02% | PLN 25.5B | PLN 389.84 | 0.02% up | 396% up | ||
| 13 | BiogenBIIB · Health Care | -0.34% | PLN 148.8B | PLN 1,006.33 | 0.34% down | 49% up | ||
| 14 | QiagenQGEN · Health Care | -0.41% | PLN 41.2B | PLN 199.49 | 0.41% down | 12% up | ||
| 15 | Kymera TherapeuticsKYMR · Health Care | -0.44% | PLN 41.6B | PLN 487.16 | 0.44% down | 87% up | ||
| 16 | argenxARGX · Health Care | -0.45% | PLN 238.8B | PLN 3,797.90 | 0.45% down | 4% up | ||
| 17 | Gilead SciencesGILD · Health Care | -0.48% | PLN 846.2B | PLN 682.26 | 0.48% down | 33% up | ||
| 18 | VaxcytePCVX · Health Care | -0.69% | PLN 37.6B | PLN 237.52 | 0.69% down | 22% up | ||
| 19 | Adaptive BiotechnologiesADPT · Health Care | -0.81% | PLN 18.4B | PLN 113.79 | 0.81% down | 88% up | ||
| 20 | BioNTechBNTX · Health Care | -0.89% | PLN 84B | PLN 338.65 | 0.89% down | 16% down | ||
| 21 | Revolution MedicinesRVMD · Health Care | -1.23% | PLN 139.9B | PLN 647.01 | 1.23% down | 131% up | ||
| 22 | Neurocrine BiosciencesNBIX · Health Care | -1.86% | PLN 66.4B | PLN 655.67 | 1.86% down | 20% up | ||
| 23 | AmgenAMGN · Health Care | -2.40% | PLN 973.4B | PLN 1,799.55 | 2.40% down | 34% up | ||
| 24 | ModernaMRNA · Health Care | -2.55% | PLN 328.3B | PLN 811.47 | 2.55% down | 755% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 4.0265 PLN).
Questions and answers
Which biotech rank first by today's price change?
Repligen (+5.60%), ImmunityBio (+5.59%) and Scholar Rock Holding (+4.48%) are the top three of the 24 biotech ranked by today's price change as of 18 Nov 2026, 16:31 UTC.
How many biotech are in this ranking?
24 are ranked by today's price change.
What are these biotech worth together?
The 24 biotech ranked by today's price change have a combined market value of PLN 3.39T as of 18 Nov 2026, 16:31 UTC.
What does ranking by today's price change measure?
How far the share price has moved since the previous close.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Biotech by today's price change”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=day-change
Underlying data: Yahoo Finance; SEC EDGAR.